STOCK TITAN
  1. Home
  2. Sec-filings
  3. IBO
  4. [PRE 14C] Impact BioMedical, Inc. Preliminary Information Statement

[PRE 14C] Impact BioMedical, Inc. Preliminary Information Statement

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
PRE 14C
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock IBO logo
Impact Biomedical, Inc.

NYSE:IBO

IBO Rankings

#8664 Ranked by Market Cap
N/A Ranked by Dividends

IBO Latest News

Jun 23, 2025
Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger
Mar 21, 2025
Impact Biomedical Inc. Announcement Stock Activity/Pricing
Feb 26, 2025
Impact Biomedical Inc. Announces Acquisition of Celios®, “Protecting People, Plants, and Animals from the World’s Most Dangerous Pathogens With Clean-Room Air Quality”
Jan 23, 2025
Impact BioMedical Inc. to Present at The Microcap Conference
Nov 19, 2024
Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

IBO Latest SEC Filings

Jun 23, 2025
[8-K] Impact BioMedical, Inc. Reports Material Event

IBO Stock Data

6.92M
7.50M
55.16%
1.89%
0.08%
Biotechnology
Pharmaceutical Preparations
Link
United States
HOUSTON